Web NewDrugInformation.com

Travasol 3.5% Sulfite Free W/ Electrolytes In Plastic Container Drug - Travasol 3.5% Sulfite Free W/ Electrolytes In Plastic Container The trade name of the product as shown on the labeling. Dosage - INJECTABLE; INJECTION The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Amino Acids; Magnesium Chloride; Potassium Phosphate, Dibasic; Sodium Acetate; Sodium Chloride Multiple ingredients are in alphabetical order. Strength - 3.5%;51MG/100ML;131MG/100ML;218MG/100ML;35MG/100ML The potency of the active ingredient(s), Amino Acids; Magnesium Chloride; Potassium Phosphate, Dibasic; Sodium Acetate; Sodium Chloride. May repeat for multiple part products. Applicant - BAXTER HLTHCARE The firm name holding legal responsibility for Travasol 3.5% Sulfite Free W/ Electrolytes In Plastic Container. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 020177 The FDA assigned number to Travasol 3.5% Sulfite Free W/ Electrolytes In Plastic Container. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Travasol 3.5% Sulfite Free W/ Electrolytes In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Oct 23, 1995 The date Travasol 3.5% Sulfite Free W/ Electrolytes In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Travasol 3.5% Sulfite Free W/ Electrolytes In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Travasol 3.5% Sulfite Free W/ Electrolytes In Plastic Container is in. Format is RX, OTC, DISCN. Applicant Full Name - Baxter Healthcare Corp The full name of the firm holding legal responsibility for the new application of Travasol 3.5% Sulfite Free W/ Electrolytes In Plastic Container. Travasol 3.5% Sulfite Free W/ Electrolytes In Plastic Container Aminosyn Ii 7% W/ Electrolytes 7%;102mg/100ml;45mg/100ml;522mg/100ml;410mg/100ml Injectable; Injection Aminosyn Ii 8.5% W/ Electrolytes 8.5%;102mg/100ml;45mg/100ml;522mg/100ml;410mg/100ml Injectable; Injection Aminosyn Ii 3.5% M 3.5%;30mg/100ml;97mg/100ml;120mg/100ml;49mg/100ml Injectable; Injection Travasol 3.5% Sulfite Free W/ Electrolytes In Plastic Container 3.5%;51mg/100ml;131mg/100ml;218mg/100ml;35mg/100ml Injectable; Injection Aminosyn 3.5% M In Plastic Container 3.5%;21mg/100ml;40mg/100ml;128mg/100ml;234mg/100ml Injectable; Injection Freamine Iii 3% W/ Electrolytes 3%;54mg/100ml;40mg/100ml;150mg/100ml;200mg/100ml;120mg/100ml Injectable; Injection Aminosyn 3.5% M 3.5%;21mg/100ml;128mg/100ml;234mg/100ml Injectable; Injection Aminosyn Ii 3.5% M In Plastic Container 3.5%;32mg/100ml;128mg/100ml;222mg/100ml;49mg/100ml Injectable; Injection Veinamine 8% 8%;61mg/100ml;211mg/100ml;56mg/100ml;388mg/100ml Injectable; Injection Aminosyn Ii 10% W/ Electrolytes 10%;102mg/100ml;45mg/100ml;522mg/100ml;410mg/100ml Injectable; Injection NewDrugInformation